Pharma R&D ROI bounced back in 2023 after record low in 2022
Pharma ROI for research and development rose 4.1% in 2023 compared to a record low of 1.2% in 2022.
Stay updated with breaking news from Pete Lyons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma ROI for research and development rose 4.1% in 2023 compared to a record low of 1.2% in 2022.
/PRNewswire/ -- Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022's...
Even in a year that saw new drugs for Alzheimer's disease and cancer greenlighted for use in the United States, treatments for weight loss garnered a bulk of health-related headlines in 2023.
Second travel business built by Hanish Sodha, a refugee from Uganda in 1970s
A team of researchers from the University of Brighton is actively involved in a pioneering initiative to develop the world's first hydrogen-powered crematorium. Click to read more...